Value Proposition


Novel Therapy

MC Sciences is worldwide in a unique position to secure a first-in-class novel mast cell therapy platform.

Clinical Human Proof-of-Concept

High probability for clinical phase success based on proven in-human efficacy results.

New Class
of Substances

Therapy platform builds upon a novel discovered target and a new class of substances with clearly identified pharmacophore.

Expected Good
Safety Profile

Expected good safety profile based on experience of first in-human clinical tests with substance derivatives.

Enormous Market

Focus on clinical indications with high unmet clinical needs and further large line extension potential.

Access to
Large Patient Pools

Access to large patient pools for quick start of clinical trials supported by globally recognized medical advisory board.